Plain-English translation of NCT07203339 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two treatments for fibromyalgia: a home-based brain stimulation device called transcranial direct current stimulation (tDCS) and duloxetine, an antidepressant medication commonly used for fibromyalgia pain. Both groups will also do physical exercise and learn about pain management. Researchers want to know if the brain stimulation device works just as well as the medication, with fewer side effects.
Many people with fibromyalgia stop taking antidepressants and anticonvulsants because of side effects or because they don't work well enough. This trial explores brain stimulation as a safer, lower-cost alternative that might help more people manage their pain without troublesome medication effects.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to receive either the home brain stimulation device or the medication (duloxetine). You'll complete 28 sessions of your assigned treatment at home after receiving training. Throughout the study, you'll also participate in physical exercise and pain education, and attend visits for pain assessments, blood tests, and brain activity measurements. The entire trial lasts several months.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Brazil